References
- Branski RC, Saltman B, Sulica L, Szeto H, Duflo S, Felsen D, Kraus DH. 2009. Cigarette smoke and reactive oxygen species metabolism: Implications for the pathophysiology of Reinke’s edema. Laryngoscope 119:2014–2018.
- Marcotullio D, Magliulo G, Pezone T. 2002. Reinke’s edema and risk factors: Clinical and histopathologic aspects. Am J Otolaryngol 23:81–84.
- Pastuszek P, Krecicki T, Zalesska-Krecicka M, Jelen M, Rak J, Krajewska B. 2003. Histological and electron microscopic investigation of Reinke’s edema. Pol J Pathol 54:61–64.
- Moesgaard Nielsen V, Højslet PE, Palvio D. 1986. Reinke’s oedema: A premalignant condition? J Laryngol Otol 100:1159–1162.
- Martins RH, Fabro AT, Domingues MA, Chi AP, Gregório EA. 2009. Is Reinke’s edema a precancerous lesion? Histological and electron microscopic aspects. J Voice 23:721–725.
- Calli C, Calli A, Pinar E, Oncel S, Tatar B. 2011. Prognostic significance of p63, p53 and ki67 expression in laryngeal basaloid squamous cell carcinomas. B-ENT 7:37–42.
- Zilfou JT, Lowe SW. 2009. Tumor suppressive functions of p53. Cold Spring Harb Perspect Biol 1:a001883.
- Goh AM, Coffill CR, Lane DP. 2011. The role of mutant p53 in human cancer. J Pathol 223:116–126.
- Anghelina F, Ionita E, Popescu CF, Ionita I, Mogoanta C, Ciolofan S, Mogoanta L. 2006. Clinical, morphological and immunohistochemical aspects in laryngeal premalignant lesions. Rom J Morphol Embryol 47:169–174.
- Luo K, Wang Z, Wang N, Zhang X, Yang J. 2005. [Effect of expression of p53 in squamous cell carcinoma of larynx and mucosa adjacent to tumor on the biological behavior]. Lin Chuang Er Bi Yan Hou Ke Za Zhi 19:405–408.
- Choi HR, Batsakis JG, Zhan F, Sturgis E, Luna MA, El-Naggar AK. 2002. Differential expression of p53 gene family members p63 and p73 in head and neck squamous tumorigenesis. Hum Pathol 33:158–164.
- Ingle RR, Setzen G, Koltai PJ, Monte D, Pastore J, Jennings TA. 1997. p53 protein expression in benign lesions of the upper respiratory tract. Arch Otolaryngol Head Neck Surg 123:297–300.
- Golusinski P, Lamperska K, Pazdrowski J, Golusinski W. 2011. [Analysis of mutations within the TP53 gene in patients with squamous cell carcinoma of the head and neck]. Otolaryngol Pol 65:114–121.
- Rodríguez Tojo MJ, García Cano FJ, Infante Sánchez JC, Velázquez Fernández E, Aguirre Urízar JM. 2005. Immunoexpression of p53, Ki-67 and E-cadherin in basaloid squamous cell carcinoma of the larynx. Clin Transl Oncol 7:110–114.
- Tandon S, Tudur-Smith C, Riley RD, Boyd MT, Jones TM. 2010. A systematic review of p53 as a prognostic factor of survival in squamous cell carcinoma of the four main anatomical subsites of the head and neck. Cancer Epidemiol Biomarkers Prev 19:574–587.
- Wolf C, Flechtenmacher C, Dietz A, Weidauer H, Abel U, Maier H, Bosch FX. 2004. p53-positive tumor-distant squamous epithelia of the head and neck reveal selective loss of chromosome 17. Laryngoscope 114:698–704.
- Gallo O, Santucci M, Franchi A. 1997. Cumulative prognostic value of p16/CDKN2 and p53 oncoprotein expression in premalignant laryngeal lesions. J Natl Cancer Inst 89:1161–1163.
- Leyva-Huerta ER, Ledesma-Montes C, Rojo-Botello RE, Vega-Memije E. 2012. P53 and bcl-2 immunoexpression in patients with oral lichen planus and oral squamous cell carcinoma. Med Oral Patol Oral Cir Bucal 17:e745–e750.
- Han BF, Wu PF, Pan J, Li Y, Li LJ. 2011. [Expression and its relationship of murine double minute 2 and P53 protein in oral leukoplakia and squamous cell carcinoma]. Hua Xi Kou Qiang Yi Xue Za Zhi 29:79–82.